Profound Medical CORP (PROF) — 13F Holders Deep Dive (Q2 2026)

PROF ranks #5750 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

59 institutions disclose a position in PROF, but none treat it as a major bet — even Gagnon Advisors, LLC, its most concentrated holder, allocates just 4.2% of its own portfolio to it.

PROF is down 0.1% today, but institutions show net buying of $1.0M this quarter — a divergence between today's price move and the underlying institutional flow.

PROF reported a net loss of $32.7M over the trailing twelve months.

• Not yet profitable — net loss of $32.7M over the trailing twelve months
• Revenue grew 61.2% year over year
• Net income improved year over year, from -$40.7M to -$32.7M
• Operating cash flow was negative, using $38.2M in cash
• Current ratio of 12.52x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.17x equity — within a conventional range